<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2355">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01560975</url>
  </required_header>
  <id_info>
    <org_study_id>TF-1108</org_study_id>
    <nct_id>NCT01560975</nct_id>
  </id_info>
  <brief_title>IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure</brief_title>
  <official_title>A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sensimed AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sensimed AG</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep apnea is characterized by repetitive episodes of decreased or interrupted airflow in
      the upper airways during sleep. Obstructive sleep apnea syndrome (OSAS) is the most common
      sleep-related breathing disorder and is characterized by repeated partial or complete upper
      airway collapse, gasping episodes, daytime sleepiness and fatigue. Once suspected, the
      diagnosis is made on the basis of anamnesis and a polysomnography (PSG) using the so-called
      respiratory disturbance index (RDI) to grade OSAS. Standard therapy consists of continuous
      positive airway pressure (CPAP) during sleep to prevent upper airway collapse. The
      association between OSAS and glaucoma has been extensively studied, although a few reports
      have been non-confirmatory. OSAS has been associated with reduced ocular blood flow, leading
      to hypoxia and hypercapnia, and as such, may represent a risk factor for glaucomatous optic
      neuropathy. OSAS has also been related to loss of nycthemeral rhythm of intraocular pressure
      (IOP). In addition, CPAP has been reported to increase IOP when used during nighttime.

      The purpose of this study is to investigate how IOP varies in time, particularly during
      sleep in OSAS patients with or without glaucoma, and if the IOP variations are associated
      with the use of CPAP. IOP fluctuations will be monitored with SENSIMED Triggerfish®, a
      portable investigational device using a contact lens sensor that monitors the IOP
      fluctuation continuously over 24-hours.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Relationship Between IOP Fluctuation Pattern With or Without CPAP Therapy in Patients With Moderate to Severe OSAS With or Without POAG</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>24-hour IOP fluctuation pattern recorded using Triggerfish in patients with moderate to severe OSAS.
using CPAP in patients with or without POAG
not using CPAP in patients with or without POAG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship Between the 24-hour IOP Fluctuation Patterns and Physiologic Parameters</measure>
    <time_frame>24-hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Heart rate and ocular pulsation rate during sleep:
using CPAP in patients with or without POAG
not using CPAP in patients with or without POAG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect After CPAP Removal on the IOP Pattern</measure>
    <time_frame>30 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>IOP pattern immediately after CPAP removal upon waking in patients with or without POAG</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Primary Open-angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Sensimed Triggerfish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SENSIMED Triggerfish®</intervention_name>
    <description>Portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours</description>
    <arm_group_label>Sensimed Triggerfish</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a confirmed diagnosis of moderate to severe OSAS, determined by a RDI &gt;
             15 on PSG

          -  Patient has either POAG with controlled IOP or no glaucoma. Five of each will
             included in the study

          -  Patients under CPAP therapy

          -  Aged ≥ 18 years, of either sex

          -  Not more than 4 diopters spherical equivalent on the study eye

          -  Not more than 2 diopters cylinder equivalent on the study eye

          -  Have given written informed consent, prior to any investigational procedures

        Exclusion Criteria:

          -  Sleep disorders other than OSAS

          -  Use of sleep medication

          -  Patients with history of intraocular surgery (including laser therapy) within the
             last 3 months

          -  Corneal or conjunctival abnormality hindering contact lens adaptation

          -  Severe dry eye syndrome

          -  Patients with allergy to corneal anesthetic

          -  Patients with contraindications for silicone contact lens wear

          -  Patients not able to understand the character and individual consequences of the
             investigation

          -  Participation in other clinical research within the last 30 days
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Ritch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New York Eye and Ear infirmary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The New York Eye and Ear Infirmary</name>
      <address>
        <city>New-York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <lastchanged_date>December 21, 2015</lastchanged_date>
  <firstreceived_date>March 20, 2012</firstreceived_date>
  <firstreceived_results_date>November 18, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sensimed Triggerfish</title>
          <description>SENSIMED Triggerfish®: Portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sensimed Triggerfish</title>
          <description>SENSIMED Triggerfish®: Portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="65.2" spread="8.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="8"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Relationship Between IOP Fluctuation Pattern With or Without CPAP Therapy in Patients With Moderate to Severe OSAS With or Without POAG</title>
        <description>24-hour IOP fluctuation pattern recorded using Triggerfish in patients with moderate to severe OSAS.
using CPAP in patients with or without POAG
not using CPAP in patients with or without POAG</description>
        <time_frame>24 hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>POAG/CPAP</title>
            <description>POAG patients with CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>noPOAG/CPAP</title>
            <description>Subjects with CPAP</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Relationship Between IOP Fluctuation Pattern With or Without CPAP Therapy in Patients With Moderate to Severe OSAS With or Without POAG</title>
            <description>24-hour IOP fluctuation pattern recorded using Triggerfish in patients with moderate to severe OSAS.
using CPAP in patients with or without POAG
not using CPAP in patients with or without POAG</description>
            <units>mVEq/h</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="44.4" spread="34.8"/>
                  <measurement group_id="O2" value="42.2" spread="40.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relationship Between the 24-hour IOP Fluctuation Patterns and Physiologic Parameters</title>
        <description>Heart rate and ocular pulsation rate during sleep:
using CPAP in patients with or without POAG
not using CPAP in patients with or without POAG</description>
        <time_frame>24-hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>POAG/CPAP</title>
            <description>POAG patients with CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>noPOAG/CPAP</title>
            <description>no POAG patients with CPAP therapy</description>
          </group>
          <group group_id="O3">
            <title>POAG/no CPAP</title>
            <description>POAG patients without CPAP therapy</description>
          </group>
          <group group_id="O4">
            <title>noPOAG/ no CPAP</title>
            <description>No POAG patients without CPAP therapy</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                  <measurement group_id="O3" value="4"/>
                  <measurement group_id="O4" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Relationship Between the 24-hour IOP Fluctuation Patterns and Physiologic Parameters</title>
            <description>Heart rate and ocular pulsation rate during sleep:
using CPAP in patients with or without POAG
not using CPAP in patients with or without POAG</description>
            <units>Correlation</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.36" spread="0.4"/>
                  <measurement group_id="O2" value="0.92" spread="0.03"/>
                  <measurement group_id="O3" value="0.47" spread="0.33"/>
                  <measurement group_id="O4" value="0.42" spread="0.20"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect After CPAP Removal on the IOP Pattern</title>
        <description>IOP pattern immediately after CPAP removal upon waking in patients with or without POAG</description>
        <time_frame>30 min</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>POAG/CPAP</title>
            <description>POAG patients with CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>noPOAG/CPAP</title>
            <description>no POAG patients with CPAP therapy</description>
          </group>
          <group group_id="O3">
            <title>POAG/no CPAP</title>
            <description>POAG patients without CPAP therapy</description>
          </group>
          <group group_id="O4">
            <title>noPOAG/ no CPAP</title>
            <description>No POAG patients without CPAP therapy</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                  <measurement group_id="O3" value="4"/>
                  <measurement group_id="O4" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Effect After CPAP Removal on the IOP Pattern</title>
            <description>IOP pattern immediately after CPAP removal upon waking in patients with or without POAG</description>
            <units>mvEq</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="-2.6" spread="54"/>
                  <measurement group_id="O2" value="-25.4" spread="69.1"/>
                  <measurement group_id="O3" value="-40.4" spread="89.2"/>
                  <measurement group_id="O4" value="-50.3" spread="91.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sensimed Triggerfish</title>
          <description>SENSIMED Triggerfish®: Portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert Ritch</name_or_title>
      <organization>NYEE</organization>
      <phone>+1 212 477 7540</phone>
      <email>ritchmd@earthlink.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
